1-25805163-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_020451.3(SELENON):​c.425G>A​(p.Cys142Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.797 in 1,613,436 control chromosomes in the GnomAD database, including 514,758 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C142S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.80 ( 48238 hom., cov: 30)
Exomes 𝑓: 0.80 ( 466520 hom. )

Consequence

SELENON
NM_020451.3 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: 0.869

Publications

37 publications found
Variant links:
Genes affected
SELENON (HGNC:15999): (selenoprotein N) This gene encodes a glycoprotein that is localized in the endoplasmic reticulum. It plays an important role in cell protection against oxidative stress, and in the regulation of redox-related calcium homeostasis. Mutations in this gene are associated with early onset muscle disorders, referred to as SEPN1-related myopathy. SEPN1-related myopathy consists of 4 autosomal recessive disorders, originally thought to be separate entities: rigid spine muscular dystrophy (RSMD1), the classical form of multiminicore disease, desmin related myopathy with Mallory-body like inclusions, and congenital fiber-type disproportion (CFTD). This protein is a selenoprotein, containing the rare amino acid selenocysteine (Sec). Sec is encoded by the UGA codon, which normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, designated the Sec insertion sequence (SECIS) element, that is necessary for the recognition of UGA as a Sec codon, rather than as a stop signal. A second stop-codon redefinition element (SRE) adjacent to the UGA codon has been identified in this gene (PMID:15791204). SRE is a phylogenetically conserved stem-loop structure that stimulates readthrough at the UGA codon, and augments the Sec insertion efficiency by SECIS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2016]
SELENON Gene-Disease associations (from GenCC):
  • rigid spine muscular dystrophy 1
    Inheritance: AR Classification: DEFINITIVE Submitted by: Ambry Genetics, G2P
  • SELENON-related myopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • congenital myopathy 4A, autosomal dominant
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • congenital fiber-type disproportion myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • desmin-related myopathy with Mallory body-like inclusions
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • rigid spine syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=8.500975E-7).
BP6
Variant 1-25805163-G-A is Benign according to our data. Variant chr1-25805163-G-A is described in ClinVar as Benign. ClinVar VariationId is 95963.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.913 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020451.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SELENON
NM_020451.3
MANE Select
c.425G>Ap.Cys142Tyr
missense
Exon 4 of 13NP_065184.2
SELENON
NM_206926.2
c.323G>Ap.Cys108Tyr
missense
Exon 3 of 12NP_996809.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SELENON
ENST00000361547.7
TSL:1 MANE Select
c.425G>Ap.Cys142Tyr
missense
Exon 4 of 13ENSP00000355141.2
SELENON
ENST00000374315.1
TSL:5
c.323G>Ap.Cys108Tyr
missense
Exon 3 of 12ENSP00000363434.1
SELENON
ENST00000354177.9
TSL:5
c.323G>Ap.Cys108Tyr
missense
Exon 3 of 12ENSP00000346109.5

Frequencies

GnomAD3 genomes
AF:
0.795
AC:
120726
AN:
151832
Hom.:
48208
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.781
Gnomad AMI
AF:
0.962
Gnomad AMR
AF:
0.853
Gnomad ASJ
AF:
0.782
Gnomad EAS
AF:
0.935
Gnomad SAS
AF:
0.887
Gnomad FIN
AF:
0.735
Gnomad MID
AF:
0.880
Gnomad NFE
AF:
0.781
Gnomad OTH
AF:
0.804
GnomAD2 exomes
AF:
0.818
AC:
203922
AN:
249190
AF XY:
0.817
show subpopulations
Gnomad AFR exome
AF:
0.778
Gnomad AMR exome
AF:
0.906
Gnomad ASJ exome
AF:
0.789
Gnomad EAS exome
AF:
0.943
Gnomad FIN exome
AF:
0.722
Gnomad NFE exome
AF:
0.783
Gnomad OTH exome
AF:
0.809
GnomAD4 exome
AF:
0.798
AC:
1165750
AN:
1461486
Hom.:
466520
Cov.:
63
AF XY:
0.800
AC XY:
581511
AN XY:
727024
show subpopulations
African (AFR)
AF:
0.779
AC:
26080
AN:
33470
American (AMR)
AF:
0.900
AC:
40263
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.789
AC:
20611
AN:
26136
East Asian (EAS)
AF:
0.932
AC:
37006
AN:
39700
South Asian (SAS)
AF:
0.877
AC:
75614
AN:
86248
European-Finnish (FIN)
AF:
0.724
AC:
38525
AN:
53194
Middle Eastern (MID)
AF:
0.853
AC:
4848
AN:
5684
European-Non Finnish (NFE)
AF:
0.786
AC:
874280
AN:
1111954
Other (OTH)
AF:
0.804
AC:
48523
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
14449
28898
43347
57796
72245
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20706
41412
62118
82824
103530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.795
AC:
120808
AN:
151950
Hom.:
48238
Cov.:
30
AF XY:
0.796
AC XY:
59117
AN XY:
74266
show subpopulations
African (AFR)
AF:
0.781
AC:
32304
AN:
41380
American (AMR)
AF:
0.853
AC:
13026
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.782
AC:
2713
AN:
3468
East Asian (EAS)
AF:
0.935
AC:
4828
AN:
5164
South Asian (SAS)
AF:
0.887
AC:
4259
AN:
4804
European-Finnish (FIN)
AF:
0.735
AC:
7777
AN:
10584
Middle Eastern (MID)
AF:
0.881
AC:
259
AN:
294
European-Non Finnish (NFE)
AF:
0.781
AC:
53068
AN:
67972
Other (OTH)
AF:
0.806
AC:
1699
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1239
2478
3716
4955
6194
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
870
1740
2610
3480
4350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.792
Hom.:
149203
Bravo
AF:
0.803
TwinsUK
AF:
0.791
AC:
2933
ALSPAC
AF:
0.786
AC:
3029
ExAC
AF:
0.814
AC:
98384
Asia WGS
AF:
0.910
AC:
3165
AN:
3478
EpiCase
AF:
0.796
EpiControl
AF:
0.802

ClinVar

Significance: Benign
Submissions summary: Benign:14
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:8
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Jun 08, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Dec 11, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This is a RefSeq error. The reference base (c.425G) is the minor allele. This al lele (G) has been identified in has been identified in 27% (1834/6748) of Finnis h chromosmes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitu te.org; dbSNP rs7349185) and thus meets criteria to be classified as benign.

Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 05, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Eichsfeld type congenital muscular dystrophy Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Dec 18, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SEPN1-related disorder Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.046
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
14
DANN
Benign
0.32
DEOGEN2
Benign
0.054
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.0076
N
LIST_S2
Benign
0.11
T
MetaRNN
Benign
8.5e-7
T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
1.1
L
PhyloP100
0.87
PrimateAI
Benign
0.44
T
PROVEAN
Benign
3.1
N
REVEL
Benign
0.043
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.054
MPC
0.39
ClinPred
0.00084
T
GERP RS
1.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.035
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7349185; hg19: chr1-26131654; COSMIC: COSV62525203; API